Alloplastic bone graft new osteoconductive products useful in periodontal diseases

new osteoconductive and osteoinductive products useful in periodontal diseases and bone regeneration

Published On 2022-05-12 13:30 GMT   |   Update On 2022-05-12 13:30 GMT

Alloplastic bone graft products may be new osteoconductive and osteoinductive products useful in periodontal diseases and bone regeneration. However careful selection of alloplastic bone graft products is necessary to achieve predictable outcomes according to each clinical situation,according to a recent study published in the Materials. Various bone graft products are...

Login or Register to read the full article

Alloplastic bone graft products may be new osteoconductive and osteoinductive products useful in periodontal diseases and bone regeneration. However careful selection of alloplastic bone graft products is necessary to achieve predictable outcomes according to each clinical situation,according to a recent study published in the Materials.

Various bone graft products are commercially available worldwide. However, there is no clear consensus regarding the appropriate bone graft products in different clinical situations.

This review is intended to summarize bone graft products, especially alloplastic bone substitutes that are available in multiple countries. It also provides dental clinicians with detailed and accurate information concerning these products. Furthermore, it discusses the prospects of alloplastic bone substitutes based on an analysis of the current market status, as well as a comparison of trends among countries. In this review, researchers focus on alloplastic bone substitutes approved in the United States, Japan, and Korea for use in periodontal and bone regeneration. According to the Food and Drug Administration database, 87 alloplastic bone graft products have been approved in the United States since 1996. According to the Pharmaceuticals and Medical Devices Agency database, 10 alloplastic bone graft products have been approved in Japan since 2004.

According to the Ministry of Health and Welfare database, 36 alloplastic bone graft products have been approved in Korea since 1980. The approved products are mainly hydroxyapatite, β-tricalcium phosphate, and biphasic calcium phosphate. The formulations of the products differed among countries. The development of new alloplastic bone products has been remarkable.

In the near future, alloplastic bone substitutes with safety and standardized quality may be the first choice instead of autologous bone; they may offer new osteoconductive and osteoinductive products with easier handling form and an adequate resorption rate, which can be used with growth factors and/or cell transplantation.

Thus, Careful selection of alloplastic bone graft products is necessary to achieve predictable outcomes according to each clinical situation

Reference:

Alloplastic Bone Substitutes for Periodontal and Bone Regeneration in Dentistry: Current Status and Prospects by Shunsuke Fukuba et al. published in the Materials.

https://doi.org/10.3390/ma14051096





Tags:    
Advertisement
Article Source : Materials

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News